AstraZeneca shares up after breast cancer drug shows positive results
Shares in AstraZeneca got a further boost today, rising 2% after posting positive late-stage trial results for breast cancer treatment Enhertu which demonstrated clinically-meaningful progression-free survival improvements.
This follows strong market-beating first-quarter results last week (25 April) which sent the shares up 5% to a new 52-week high. Today's gain sees the shares up 13% for th...